Sara Salerno
- Hematology top 2%
- Molecular Biology
- Genetics top 5%
- Pediatrics, Perinatology and Child Health
- Oncology
- Co-authors
- Neil P. ShahLauren E. DamonCatherine C. SmithPatrick P. ZarrinkarJeremy P. HuntAlexander E. PerlMark J. LevisAndrew Kasarskis
- Topics
- Chronic Myeloid Leukemia Treatments (8 papers)Acute Myeloid Leukemia Research (7 papers)Antibiotics Pharmacokinetics and Efficacy (6 papers)
- Cited by
- HematologyGeneticsMolecular Biology
- Journals
- NatureBloodCancer Research
- Partner nations
- United StatesCanadaSouth Africa
In The Last Decade
Sara Salerno
19 papers receiving 929 citations
Hit Papers
Peers
Comparison fields: 5 of 76
- Hematology 586
- Molecular Biology 397
- Genetics 272
- Pediatrics, Perinatology and Child Health 89
- Oncology 84
Countries citing papers authored by Sara Salerno
This map shows the geographic impact of Sara Salerno's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sara Salerno with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sara Salerno more than expected).
Fields of papers citing papers by Sara Salerno
This network shows the impact of papers produced by Sara Salerno. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sara Salerno. The network helps show where Sara Salerno may publish in the future.
Co-authorship network of co-authors of Sara Salerno
This figure shows the co-authorship network connecting the top 25 collaborators of Sara Salerno. A scholar is included among the top collaborators of Sara Salerno based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sara Salerno. Sara Salerno is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 7 | |
| 2 | 6 | |
| 3 | 9 | |
| 4 | 38 | |
| 5 | 31 | |
| 6 | 14 | |
| 7 | 30 | |
| 8 | 7 | |
| 9 | 12 | |
| 10 | 11 | |
| 11 | 45 | |
| 12 | 101 | |
| 13 | Validation of ITD mutations in FLT3 as a therapeutic target in human acute myeloid leukaemiabreakdown → | 542 |
| 14 | 4 | |
| 15 | 1 | |
| 16 | 1 | |
| 17 | 4 | |
| 18 | 3 | |
| 19 | 82 |
About Sara Salerno
Sara Salerno is a scholar working on Hematology, Genetics and Pharmacology, having authored 19 papers that have together received 948 indexed citations. Recurring topics across this work include Chronic Myeloid Leukemia Treatments (8 papers), Acute Myeloid Leukemia Research (7 papers) and Antibiotics Pharmacokinetics and Efficacy (6 papers). The work is most often cited by research in Hematology (586 citations), Genetics (272 citations) and Molecular Biology (397 citations). Sara Salerno has collaborated with scholars based in United States, Canada and South Africa. Frequent co-authors include Neil P. Shah, Lauren E. Damon, Catherine C. Smith, Patrick P. Zarrinkar, Jeremy P. Hunt, Alexander E. Perl, Mark J. Levis, Andrew Kasarskis, Kevin Travers and Susana Wang. Their work appears in journals such as Nature, Blood and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.